CDMO FAQ

CDMO Insurance Questions, Answered

Each entry below is a buyer-side question pharmaceutical contract manufacturers ask, with a 200-word plain-English answer and links to the relevant practice page, glossary clause, or longer Q&A entry. For sponsor-specific MSA review, run the free MSA Decoder.

• What is contract manufacturing in pharma?

  Pharma contract manufacturing is the outsourced production of drug substances or finished drug products under a sponsor agreement. Insurance and indemnity structure are part of the contract architecture.

• What is the difference between a manufacturer and a contract manufacturer?

  A manufacturer holds the product regulatory authorization (NDA, BLA, 510(k)); a contract manufacturer produces under that authorization for the sponsor. Insurance and indemnity flow differently between them.

• What are typical CDMO contract terms?

  Typical CDMO contract terms include scope of work, regulatory responsibility allocation, quality agreement, IP ownership, indemnity, insurance schedule, term and termination, and dispute resolution. The insurance schedule is often the most negotiated.

• What are common CDMO insurance challenges?

  The recurring CDMO insurance challenges: sponsor MSA scope creep, products liability tower adequacy, recall execution funding, cGMP validation property losses, and IP / trade secret exposure across sponsor work.

• What happens if cGMP is not followed?

  cGMP non-compliance triggers FDA Warning Letters, consent decrees, product seizures, import alerts, and criminal liability. Insurance covers defense and some remediation but not regulatory fines or the underlying compliance investment.

• What are examples of cGMP violations that affect insurance?

  Common cGMP violations producing insurance consequences: data integrity failures, environmental monitoring deficiencies, inadequate CAPAs, microbial contamination, and validation lapses. Each affects products liability and renewal pricing.

• Do manufacturers cover product recalls?

  Pharma and device manufacturers cover recalls through dedicated product recall insurance (first-party) plus the recall extension on products liability (third-party). Most operating cash cannot fund a meaningful recall.

• What is the average cost of a pharmaceutical recall?

  Pharma recall costs vary by class and scale. Class I recalls frequently reach $10M+ in first-party costs; Class II recalls run $1M-$10M; Class III recalls are typically under $1M but still meaningful for mid-market operators.

• What products liability limit does a CDMO need?

  Most sponsor MSAs require $5M to $10M products and completed operations. Oncology, sterile injectable, biologics, and controlled-substance manufacturing routinely require the higher band.

• Does a CDMO need recall insurance?

  Most sponsor MSAs increasingly require dedicated recall coverage at $1M to $5M first-party limits. The products policy sublimit on most generalist programs does not satisfy this requirement.

• What is the difference between additional insured and named insured for a CDMO sponsor MSA?

  Additional insured (AI) extends coverage to a sponsor for liability arising out of the CDMO's operations. Named insured shares policy ownership. Sponsor MSAs almost always require AI, not named insured.

• How do CDMOs handle multi-sponsor aggregate exhaustion?

  A CDMO running multiple sponsor MSAs needs per-project or per-location aggregate endorsements so one sponsor claim does not exhaust limits at the expense of every other sponsor relationship.